242 related articles for article (PubMed ID: 34764141)
1. Enteropathies with villous atrophy but negative coeliac serology in adults: current issues.
Schiepatti A; Cincotta M; Biagi F; Sanders DS
BMJ Open Gastroenterol; 2021 Nov; 8(1):. PubMed ID: 34764141
[TBL] [Abstract][Full Text] [Related]
2. Overview in the clinical management of patients with seronegative villous atrophy.
Schiepatti A; Sanders DS; Zuffada M; Luinetti O; Iraqi A; Biagi F
Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):409-417. PubMed ID: 30557227
[TBL] [Abstract][Full Text] [Related]
3. Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus.
Schiepatti A; Sanders DS; Baiardi P; Caio G; Ciacci C; Kaukinen K; Lebwohl B; Leffler D; Malamut G; Murray JA; Rostami K; Rubio-Tapia A; Volta U; Biagi F
Gut; 2022 Nov; 71(11):2218-2225. PubMed ID: 35676085
[TBL] [Abstract][Full Text] [Related]
4. Seronegative coeliac disease: clearing the diagnostic dilemma.
Schiepatti A; Sanders DS; Biagi F
Curr Opin Gastroenterol; 2018 May; 34(3):154-158. PubMed ID: 29613916
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy.
Szaflarska-Popławska A
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836279
[TBL] [Abstract][Full Text] [Related]
6. Seronegative celiac disease: Shedding light on an obscure clinical entity.
Volta U; Caio G; Boschetti E; Giancola F; Rhoden KJ; Ruggeri E; Paterini P; De Giorgio R
Dig Liver Dis; 2016 Sep; 48(9):1018-22. PubMed ID: 27352981
[TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on the Evaluation and Management of Seronegative Enteropathies: Expert Review.
Leonard MM; Lebwohl B; Rubio-Tapia A; Biagi F
Gastroenterology; 2021 Jan; 160(1):437-444. PubMed ID: 33010252
[TBL] [Abstract][Full Text] [Related]
8. Gamma delta
Fernández-Bañares F; Crespo L; Núñez C; López-Palacios N; Tristán E; Vivas S; Farrais S; Arau B; Vidal J; Roy G; Esteve M
Aliment Pharmacol Ther; 2020 Apr; 51(7):699-705. PubMed ID: 32048756
[TBL] [Abstract][Full Text] [Related]
9. Review article: Becoming and being coeliac-special considerations for childhood, adolescence and beyond.
Chang D; O'Shea D; Therrien A; Silvester JA
Aliment Pharmacol Ther; 2022 Jul; 56 Suppl 1(Suppl 1):S73-S85. PubMed ID: 35815825
[TBL] [Abstract][Full Text] [Related]
10. All that glitters is not always gold.
Harrison E; Hayes S; Howell L; Lal S
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24515230
[TBL] [Abstract][Full Text] [Related]
11. Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up.
Sharkey LM; Corbett G; Currie E; Lee J; Sweeney N; Woodward JM
Aliment Pharmacol Ther; 2013 Nov; 38(10):1278-91. PubMed ID: 24117503
[TBL] [Abstract][Full Text] [Related]
12. [Etiological diagnosis of villous atrophy].
Patey-Mariaud De Serre N; Verkarre V; Cellier C; Cerf-Bensussan N; Schmitz J; Brousse N
Ann Pathol; 2001 Aug; 21(4):319-33. PubMed ID: 11685130
[TBL] [Abstract][Full Text] [Related]
13. Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies.
Schiepatti A; Biagi F; Fraternale G; Vattiato C; Balduzzi D; Agazzi S; Alpini C; Klersy C; Corazza GR
Eur J Gastroenterol Hepatol; 2017 May; 29(5):572-576. PubMed ID: 28350748
[TBL] [Abstract][Full Text] [Related]
14. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000-2015).
Aziz I; Peerally MF; Barnes JH; Kandasamy V; Whiteley JC; Partridge D; Vergani P; Cross SS; Green PH; Sanders DS
Gut; 2017 Sep; 66(9):1563-1572. PubMed ID: 27605538
[TBL] [Abstract][Full Text] [Related]
15. Monitoring coeliac disease in 2024, time to change practice?
Raju SA; Shiha MG; Penny HA
Curr Opin Gastroenterol; 2024 May; 40(3):190-195. PubMed ID: 38547329
[TBL] [Abstract][Full Text] [Related]
16. Genetic and flow cytometry analysis of seronegative celiac disease: a cohort study.
Ríos León R; Crespo Pérez L; Rodríguez de Santiago E; Roy Ariño G; De Andrés Martín A; García Hoz Jiménez C; Sánchez Rodríguez E; Saiz González A; León Prieto F; Albillos A
Scand J Gastroenterol; 2019 May; 54(5):563-570. PubMed ID: 31057009
[No Abstract] [Full Text] [Related]
17. The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate.
Rostami K; Kerckhaert JP6 ; Tiemessen R; Meijer JW; Mulder CJ
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):439-42. PubMed ID: 10321762
[TBL] [Abstract][Full Text] [Related]
18. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy.
Abrams JA; Diamond B; Rotterdam H; Green PH
Dig Dis Sci; 2004 Apr; 49(4):546-50. PubMed ID: 15185855
[TBL] [Abstract][Full Text] [Related]
19. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease.
Kaukinen K; Peräaho M; Lindfors K; Partanen J; Woolley N; Pikkarainen P; Karvonen AL; Laasanen T; Sievänen H; Mäki M; Collin P
Aliment Pharmacol Ther; 2007 May; 25(10):1237-45. PubMed ID: 17451570
[TBL] [Abstract][Full Text] [Related]
20. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.
Tuire I; Marja-Leena L; Teea S; Katri H; Jukka P; Päivi S; Heini H; Markku M; Pekka C; Katri K
Am J Gastroenterol; 2012 Oct; 107(10):1563-9. PubMed ID: 22825364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
